Jeffrey Farrow
2020 - Global Blood Therapeutics
Compensation breakdown
| Non-Equity Incentive Plan | $231,500 |
|---|---|
| Option Awards | $1,582,504 |
| Salary | $457,813 |
| Stock Awards | $3,708,261 |
| Other | $5,000 |
| Total | $5,985,078 |
Farrow received $3.7M in stock awards, accounting for 62% of the total pay in 2020.
Farrow also received $231.5K in non-equity incentive plan, $1.6M in option awards, $457.8K in salary and $5K in other compensation.
Rankings
In 2020, Jeffrey Farrow's compensation ranked 1,739th out of 13,090 executives tracked by ExecPay. In other words, Farrow earned more than 86.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,739 out of 13,090 | 87th |
Division Manufacturing | 663 out of 5,621 | 88th |
Major group Chemicals And Allied Products | 237 out of 2,254 | 90th |
Industry group Drugs | 198 out of 1,954 | 90th |
Industry Pharmaceutical Preparations | 138 out of 1,459 | 91st |
Pay ratio
| Jeffrey Farrow's Pay | $5,985,078 |
|---|---|
| Median Employee's Pay | $373,366 |
| Pay Ratio | 16to 1 |
In 2020, the annual total compensation of Jeffrey Farrow was $5,985,078.
The annual total compensation of the median employee at Global Blood Therapeutics was $373,366.
The ratio of Jeffrey Farrow's pay to the pay of median employee was therefore 16 to one.
Farrow's colleagues
We found four more compensation records of executives who worked with Jeffrey Farrow at Global Blood Therapeutics in 2020.